Prolonged Anti‐Zic4 Antibody–Positive Cerebellar Degeneration Following <scp>COVID</scp> ‐19 Infection

This case illustrates an unusual phenotype of prolonged, isolated anti-Zic4 antibody-associated cerebellar degeneration triggered by SARS-CoV-2 infection, thus expanding the recognized clinical spectrum of Zic4-related disorders beyond paraneoplastic contexts. The underlying immunopathological mechanisms have yet to be elucidated. Notably, radiological progression was disproportionate to clinical stabilization, underscoring the necessity of long-term clinical/imaging surveillance. This case highlights the need for further studies to clarify pathophysiological links between COVID-19 and persistent autoimmune cerebellar degeneration.

Authors

Institutions

Publication Details

Journal
Neuropsychopharmacology Reports
Published
2026-02-17
DOI
https://doi.org/10.1002/npr2.70094
Primary Topic
Autoimmune Neurological Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prolonged Anti‐Zic4 Antibody–Positive Cerebellar Degeneration Following COVID ‐19 Infection

Yasushi Shimo, Takahiro Koinuma, Tsuyoshi Furuya, Hiroto Eguchi et al.
Neuropsychopharmacology Reports
Autoimmune Neurological Disorders and Treatments
article

Prolonged Anti‐Zic4 Antibody–Positive Cerebellar Degeneration Following COVID ‐19 Infection

Yasushi Shimo, Takahiro Koinuma, Tsuyoshi Furuya, Hiroto Eguchi, Atsuhito Fuse, Asuka Nakajima, Risa Suzuki‐Yamamoto
article en

Abstract

This case illustrates an unusual phenotype of prolonged, isolated anti-Zic4 antibody-associated cerebellar degeneration triggered by SARS-CoV-2 infection, thus expanding the recognized clinical spectrum of Zic4-related disorders beyond paraneoplastic contexts. The underlying immunopathological mechanisms have yet to be elucidated. Notably, radiological progression was disproportionate to clinical stabilization, underscoring the necessity of long-term clinical/imaging surveillance. This case highlights the need for further studies to clarify pathophysiological links between COVID-19 and persistent autoimmune cerebellar degeneration.

Neuropsychopharmacology ReportsVol. 46(1)
Tokyo-Kita Medical Center (JP), Juntendo University Nerima Hospital (JP)
Japan Society for the Promotion of Science
Good health and well-being
Openalex Percentile: Top 57%
Autoimmune Neurological Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Prolonged Anti‐Zic4 Antibody–Positive Cerebellar Degeneration Following <scp>COVID</scp> ‐19 Infection — Yasushi Shimo, Takahiro Koinuma, et al. · Neuropsychopharmacology Reports (2026) | TGRS Research Map | TGRS